title: [Patients with oral anticoagulant therapy].
abstract: BACKGROUND
  patients with ACO treatment must have some knowledge about the risks it causes. For this, that medical personnel must give and proper education in quality and quantity both the patient and the family.
  
  
  OBJECTIVE
  determine the knowledge level in relation with the treatment ACO that the patients treated have in an AP query in a rural healthy area like is Plasencia.
  
  
  METHODS
  an observational descriptive retrospective study was conducted with 34 patients who was being treated with ACO. Data about pathologies, biometrics parameters about the clinical historical and interviews with the patients in the nurse query were picked up.
  
  
  RESULTS
  when the data were analyzed, the number of the patients according to the sex was equaled. Not according to the ages: people between 80-90 years old were the 26.5% from the total. About the pathologies causatives of the treatment, the FA is the most frequent with the 50%, followed by the pulmonary thromboembolism with the 23%. The control of the results was distributed controlling the youngest people at the hospital, the oldest people in AP. In relation with the tracing of the treatment, people with FA and valve prosthesis were the people most fulfilled.
  
  
  CONCLUSIONS
  To the medical personnel it is necessary to know the patient ACO profile, as the risk associated treatment. Young patients with cardiovascular pathologies are controlled at the hospital for they most variation in results, controlled in older primary care patients (AP) and rural residents have greater grip and better control. With this knowledge, medical personnel would make interventions for help adherence, monitoring control, treatment as well as the collaboration of family.
authors.affiliation: argemesefe@hotmail.com
authors.forename: Argeme
authors.initials: A
authors.lastname: Serradilla Fernandez
authors.forename: M Del Mar
authors.initials: Mdel M
authors.lastname: Reyero Hernandez
authors.forename: Blanca
authors.initials: B
authors.lastname: Guerrero Chacón
authors.forename: Maria Elena
authors.initials: ME
authors.lastname: Tobajas Tobajas
authors.forename: Angel
authors.initials: A
authors.lastname: Reyero Hernández
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D063046:Patient Medication Knowledge; D012189:Retrospective Studies
chemical_list: D000925:Anticoagulants